BlogsClinical Data ServicesDataInsightsOur Thinking Significance of quantitative tools and techniques in reducing drug attrition Drug development is a complex and expensive process that involves multiple stages, including drug discovery,…Nagendran PJune 22, 2023
BlogsClinical Data ServicesDataInsightsOur Thinking A day in the life of a clinical pharmacology expert Clinical pharmacologists understand that drug development is a complex and time-consuming activity. Let’s explore how…Nagendran PMarch 9, 2023
Clinical Data ServicesDataOur ThinkingWhitepapers Optimizing preclinical toxicology data analysis with comprehensive, digitized reports To understand a drug's effect on the body, investigations take place to understand the pharmacokinetic…Ben.frew@excelra.comOctober 18, 2022
BlogsClinical Data Services Data curation for model-based meta analysis (MBMA) – an integral part of MID3 Model informed drug discovery and development (MID3) is a paradigm of data analytics in drug development…Ben.frew@excelra.comApril 14, 2022
BlogsClinical Data ServicesData Coronavirus clinical trials landscape – analysis using Excelra’s COVID-19 biomarker database The ongoing COVID-19 pandemic is continuing to spread rapidly across the globe. As of 30th…Ben.frew@excelra.comMarch 15, 2022